Previous studies divided cancers in the TCGA cohort into six immune subtypes, including Wound Healing (C1), IFN-gamma Dominant (C2), Inflammatory (C3), Lymphocyte Depleted (C4), Immunologically Quiet (C5), and TGF-beta Dominant (C6) (Thorsson et al., 2019). This evidence concerns the gene IFNG and cancer.